Cementos Bio Bio S.A. (SNSE:CEMENTOS)

Cementos Bio Bio Balance Sheet

Financials in millions CLP. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	25,926	13,619	10,673	41,183	40,517
Short-Term Investments	3,015	16.02	2.25	2.26	2.03
Cash & Short-Term Investments	28,941	13,635	10,676	41,185	40,519
Cash Growth	112.25%	27.72%	-74.08%	1.64%	89.87%
Accounts Receivable	56,809	57,268	48,290	42,425	34,387
Other Receivables	1,869	6,489	4,912	12,727	2,341
Receivables	58,678	65,638	54,925	56,276	38,589
Inventory	50,714	56,700	58,943	40,737	33,018
Prepaid Expenses	-	3,588	3,166	3,827	785.85
Other Current Assets	11,728	6,377	5,373	8,618	6,296
Total Current Assets	150,061	145,938	133,082	150,643	119,209
Property, Plant & Equipment	318,390	293,921	289,649	289,974	280,129
Long-Term Investments	942.2	-	47.02	11.78	11.78
Goodwill	12,485	12,485	12,485	12,485	12,485
Other Intangible Assets	6,335	6,099	5,914	5,699	5,643
Long-Term Accounts Receivable	580.24	507.36	534.57	776.09	286.45
Long-Term Deferred Tax Assets	21,619	21,254	21,243	16,995	17,014
Other Long-Term Assets	11,027	8,190	8,227	5,111	4,595
Total Assets	521,438	491,323	475,747	488,855	446,181
Accounts Payable	61,516	53,446	55,192	49,748	36,838
Accrued Expenses	8,509	16,564	12,752	14,577	10,136
Current Portion of Long-Term Debt	20,442	7,420	4,787	2,393	830.51
Current Portion of Leases	14,263	8,987	9,514	8,662	2,543
Current Income Taxes Payable	2,228	3,370	4,146	1,566	2,228
Current Unearned Revenue	-	2,423	312.05	445.54	323.04
Other Current Liabilities	9,345	7,334	6,873	3,862	9,159
Total Current Liabilities	116,303	99,544	93,576	81,254	62,057
Long-Term Debt	81,321	94,696	97,957	97,462	98,566
Long-Term Leases	25,916	11,895	10,560	13,950	5,192
Long-Term Deferred Tax Liabilities	19,762	20,914	24,678	32,822	28,957
Other Long-Term Liabilities	3,128	3,518	2,500	2,427	3,991
Total Liabilities	250,717	235,009	234,093	231,630	203,087
Common Stock	137,625	137,625	137,625	137,625	137,625
Retained Earnings	141,347	132,730	116,774	134,483	123,986
Comprehensive Income & Other	-8,900	-14,719	-13,411	-15,548	-19,035
Total Common Equity	270,071	255,636	240,988	256,560	242,576
Minority Interest	649.96	678.3	666.05	664.92	517.99
Shareholders' Equity	270,721	256,314	241,654	257,225	243,094
Total Liabilities & Equity	521,438	491,323	475,747	488,855	446,181
Total Debt	141,941	122,999	122,817	122,468	107,131
Net Cash (Debt)	-113,000	-109,363	-112,142	-81,283	-66,612
Net Cash Per Share	-428.62	-413.91	-424.42	-307.63	-252.11
Filing Date Shares Outstanding	263.05	264.22	264.22	264.22	264.22
Total Common Shares Outstanding	263.05	264.22	264.22	264.22	264.22
Working Capital	33,758	46,394	39,506	69,388	57,152
Book Value Per Share	1026.67	967.51	912.07	971.01	918.08
Tangible Book Value	251,252	237,052	222,589	238,377	224,448
Tangible Book Value Per Share	955.13	897.17	842.44	902.19	849.47
Land	-	11,034	11,741	10,040	11,213
Buildings	-	34,466	33,926	31,686	14,872
Machinery	-	510,583	489,786	468,909	369,779
Construction In Progress	-	10,174	16,622	24,802	6,542

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.